Skip to content

Effects of Moderate Aerobic Exercise and Inspiratory Muscle Training on selected Clinical and Haematological Parameters Among Adults with Sickle Cell Disease

Effects of Moderate Aerobic Exercise and Inspiratory Muscle Training on selected Clinical and Haematological Parameters Among Adults with Sickle Cell Disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202001495245937
Enrollment
120
Registered
2020-01-16
Start date
2022-01-03
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders

Interventions

Moderate aerobic exercise plus inspiratory muscle training

Sponsors

Bayero University Kano
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Sickle Cell Disease type HbSS following electrophoresis test 2. Restricted pattern of spirometry. 3. Adults, aged 18 years and above who are able to perform pulmonary function test. 4. Patients who can understand instructions on how to carry out the procedure involved in this study 5. A non-smoker Sickle Cell Anaemia (SCA) patient. 6. Steady state patients that have not had crises for at least 1 month and no blood transfusion. 7. Individuals with no prior asthma history.

Exclusion criteria

Exclusion criteria: 1. Chronic lung diseases unrelated to sickle cell disease, such as COPD, asthma 2. Heart disease and pulmonary hypertension 3. Individuals with avascular necrosis 4. Individuals on hydroxyuria drug

Design outcomes

Primary

MeasureTime frame
Lung Function Test

Secondary

MeasureTime frame
Respiratory muscle strength, Functional capacity, Quality of life, respiratory symptoms, Full blood count and Lactate Dehydrogenase

Countries

Nigeria

Contacts

Public ContactAISHAT SHITTU

Lecturer Bayero University Kano

ashittu.pth@buk.edu.ng+2348036785233

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026